InflaRx GmbH
🏢 View company profile →13Patents
13Active
13Granted
48Portfolio score
Filing activity: Nov 26, 2010 → May 26, 2023 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8802096B2 | Anti-C5a binding antibodies with high block activity | Chemistry; Metallurgy | 17 | Active |
| US9073983B2 | Anti-C5A binding moieties with high blocking activity | Chemistry; Metallurgy | 12 | Active |
| US9458233B2 | Anti-C5a binding moieties with high blocking activity | Chemistry; Metallurgy | 11 | Active |
| US10376595B2 | Treatment of inflammatory diseases with inhibitors of C5a activity | Chemistry; Metallurgy | 7 | Active |
| US10774136B2 | Anti-C5a binding moieties with high blocking activity | Chemistry; Metallurgy | 5 | Active |
| US11273225B2 | Treatment of inflammatory diseases with inhibitors of C5a activity | Chemistry; Metallurgy | 4 | Active |
| US11464868B2 | Treatment of inflammatory diseases with inhibitors of C5A activity | Chemistry; Metallurgy | 3 | Active |
| US11149009B2 | Fused piperidinyl bicyclic and related compounds as modulators of C5A receptor | Chemistry; Metallurgy | 3 | Active |
| US10227397B2 | Inhibitors of C5a for the treatment of viral pneumonia | Chemistry; Metallurgy | 1 | Active |
| US11999698B2 | Fused piperidinyl bicyclic and related compounds as modulators of C5a receptor | Chemistry; Metallurgy | 0 | Active |
| US11890349B2 | Treatment of inflammatory diseases with inhibitors of C5A activity | Chemistry; Metallurgy | 0 | Active |
| US10858421B2 | Inhibitors of C5A for the treatment of viral pneumonia | Chemistry; Metallurgy | 0 | Active |
| US12180274B2 | Treatment of pneumonia and ARDS with inhibitors of C5a and IL-6 activity | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.